Qian Xiao-min

1.3k total citations · 1 hit paper
17 papers, 1.1k citations indexed

About

Qian Xiao-min is a scholar working on Molecular Biology, Cancer Research and Biomaterials. According to data from OpenAlex, Qian Xiao-min has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Cancer Research and 5 papers in Biomaterials. Recurrent topics in Qian Xiao-min's work include RNA Interference and Gene Delivery (9 papers), MicroRNA in disease regulation (8 papers) and Nanoparticle-Based Drug Delivery (5 papers). Qian Xiao-min is often cited by papers focused on RNA Interference and Gene Delivery (9 papers), MicroRNA in disease regulation (8 papers) and Nanoparticle-Based Drug Delivery (5 papers). Qian Xiao-min collaborates with scholars based in China, United States and France. Qian Xiao-min's co-authors include Chunsheng Kang, Yu Ren, Xubo Yuan, Lixia Long, Chaoyong Liu, Zhendong Shi, Peiyu Pu, Hongzhao Qi, Xin Hou and Xiaodan Chang and has published in prestigious journals such as Advanced Materials, ACS Nano and Biomaterials.

In The Last Decade

Qian Xiao-min

15 papers receiving 1.1k citations

Hit Papers

Blood Exosomes Endowed wi... 2016 2026 2019 2022 2016 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qian Xiao-min China 11 867 493 254 230 71 17 1.1k
Bharat K. Majeti India 13 770 0.9× 344 0.7× 240 0.9× 307 1.3× 102 1.4× 16 1.2k
Silvia Catuogno Italy 22 1.3k 1.5× 439 0.9× 277 1.1× 105 0.5× 109 1.5× 45 1.6k
Golam Kibria Japan 11 907 1.0× 364 0.7× 271 1.1× 335 1.5× 116 1.6× 12 1.2k
Alexander Ewe Germany 18 628 0.7× 189 0.4× 216 0.9× 162 0.7× 75 1.1× 34 819
Sue Anne Chew United States 15 494 0.6× 206 0.4× 183 0.7× 136 0.6× 52 0.7× 31 889
Xiaoshan Yang China 17 687 0.8× 236 0.5× 166 0.7× 141 0.6× 199 2.8× 32 1.0k
Kun Xie China 12 676 0.8× 313 0.6× 111 0.4× 124 0.5× 43 0.6× 20 856
Chi‐Ling Chiang United States 19 549 0.6× 214 0.4× 578 2.3× 99 0.4× 88 1.2× 35 1.1k
Noemi Arrighetti Italy 14 548 0.6× 200 0.4× 187 0.7× 128 0.6× 79 1.1× 26 790

Countries citing papers authored by Qian Xiao-min

Since Specialization
Citations

This map shows the geographic impact of Qian Xiao-min's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qian Xiao-min with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qian Xiao-min more than expected).

Fields of papers citing papers by Qian Xiao-min

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qian Xiao-min. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qian Xiao-min. The network helps show where Qian Xiao-min may publish in the future.

Co-authorship network of co-authors of Qian Xiao-min

This figure shows the co-authorship network connecting the top 25 collaborators of Qian Xiao-min. A scholar is included among the top collaborators of Qian Xiao-min based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qian Xiao-min. Qian Xiao-min is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
3.
Shi, Zhendong, et al.. (2024). Co-encapsulation of granzyme B and perforin in nanocapsules for tumour therapy: biomimicking immune cells. Journal of Controlled Release. 369. 658–667. 10 indexed citations
4.
Xiao-min, Qian, et al.. (2023). Multistage‐Responsive Dual‐Enzyme Nanocascades for Synergistic Radiosensitization‐Starvation Cancer Therapy. Advanced Healthcare Materials. 12(21). e2300118–e2300118. 19 indexed citations
5.
Shi, Zhendong, et al.. (2022). A novel Granzymes and miRNA nanocapsules co-delivery system for tumor suppression. Biomedical Physics & Engineering Express. 8(6). 65035–65035. 1 indexed citations
6.
Xiao-min, Qian, Zhendong Shi, Hongzhao Qi, et al.. (2019). A novel Granzyme B nanoparticle delivery system simulates immune cell functions for suppression of solid tumors. Theranostics. 9(25). 7616–7627. 40 indexed citations
7.
Shi, Zhendong, Yang Li, Qian Xiao-min, et al.. (2017). MiR-340 Inhibits Triple-Negative Breast Cancer Progression by Reversing EZH2 Mediated miRNAs Dysregulated Expressions. Journal of Cancer. 8(15). 3037–3048. 34 indexed citations
8.
Qi, Hongzhao, Chaoyong Liu, Lixia Long, et al.. (2016). Blood Exosomes Endowed with Magnetic and Targeting Properties for Cancer Therapy. ACS Nano. 10(3). 3323–3333. 415 indexed citations breakdown →
9.
Shi, Zhendong, Qian Xiao-min, Junxia Zhang, et al.. (2014). BASI, A Potent Small Molecular Inhibitor, Inhibits Glioblastoma Progression by Targeting microRNA‐mediated β‐Catenin Signaling. CNS Neuroscience & Therapeutics. 20(9). 830–839. 8 indexed citations
10.
Liu, Chaoyong, Jing Wen, Kailiang Zhang, et al.. (2014). Efficient Delivery of Therapeutic miRNA Nanocapsules for Tumor Suppression. Advanced Materials. 27(2). 292–297. 74 indexed citations
11.
Shi, Zhendong, Junxia Zhang, Qian Xiao-min, et al.. (2013). AC1MMYR2, an Inhibitor of Dicer-Mediated Biogenesis of Oncomir miR-21, Reverses Epithelial–Mesenchymal Transition and Suppresses Tumor Growth and Progression. Cancer Research. 73(17). 5519–5531. 157 indexed citations
12.
Xiao-min, Qian, Lixia Long, Zhendong Shi, et al.. (2013). Star-branched amphiphilic PLA-b-PDMAEMA copolymers for co-delivery of miR-21 inhibitor and doxorubicin to treat glioma. Biomaterials. 35(7). 2322–2335. 160 indexed citations
13.
Shi, Zhendong, Qian Xiao-min, Junxia Zhang, et al.. (2012). Nuclear Translocation of β-catenin is Essential for Glioma Cell Survival. Journal of Neuroimmune Pharmacology. 7(4). 892–903. 52 indexed citations
14.
Shi, Zhendong, Qian Xiao-min, Chaoyong Liu, et al.. (2012). Aspirin‐/TMZ‐coloaded Microspheres Exert Synergistic Antiglioma Efficacy via Inhibition of β‐catenin Transactivation. CNS Neuroscience & Therapeutics. 19(2). 98–108. 24 indexed citations
15.
Xiao-min, Qian, Zhendong Shi, Yu Ren, et al.. (2012). Synergistic inhibition of human glioma cell line by temozolomide and PAMAM‐mediated miR‐21i. Journal of Applied Polymer Science. 127(1). 570–576. 6 indexed citations
16.
Xiao-min, Qian, Yu Ren, Zhendong Shi, et al.. (2012). Sequence-Dependent Synergistic Inhibition of Human Glioma Cell Lines by Combined Temozolomide and miR-21 Inhibitor Gene Therapy. Molecular Pharmaceutics. 9(9). 2636–2645. 64 indexed citations
17.
Chang, Jiang, Chenghu Yan, Qian Xiao-min, et al.. (2010). Development of transferrin functionalized poly(ethylene glycol)/poly(lactic acid) amphiphilic block copolymeric micelles as a potential delivery system targeting brain glioma. Journal of Materials Science Materials in Medicine. 21(9). 2673–2681. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026